Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer

To elucidate a role of apparent diffusion coefficient (ADC) value as a biomarker of bladder cancer, we investigated its associations with Ki‐67 labeling index (LI) along with classical clinicopathological prognosticators.

[1]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[2]  Toshihiro Kumabe,et al.  Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. , 2006, Radiology.

[3]  舩津 宏之,et al.  Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection , 2013 .

[4]  A. Feller,et al.  HER2 overexpression in muscle‐invasive urothelial carcinoma of the bladder: Prognostic implications , 2002, International journal of cancer.

[5]  Yutaka Imai,et al.  Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.

[6]  Zhiye Chen,et al.  Diagnostic value of minimum apparent diffusion coefficient values in prediction of neuroepithelial tumor grading , 2010, Journal of magnetic resonance imaging : JMRI.

[7]  Y. Lotan,et al.  Ki-67 Is an Independent Predictor of Bladder Cancer Outcome in Patients Treated with Radical Cystectomy for Organ-Confined Disease , 2006, Clinical Cancer Research.

[8]  T. Hirai,et al.  Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. , 2007, Radiology.

[9]  K. Kihara,et al.  Initial experience of functional imaging of upper urinary tract neoplasm by diffusion‐weighted magnetic resonance imaging , 2008, International journal of urology : official journal of the Japanese Urological Association.

[10]  Hedvig Hricak,et al.  Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience. , 2008, Radiology.

[11]  John C Gore,et al.  Sensitivity of MR diffusion measurements to variations in intracellular structure: Effects of nuclear size , 2009, Magnetic resonance in medicine.

[12]  K. Kihara,et al.  Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. , 2008, Urology.

[13]  Yuta Shibamoto,et al.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. , 2009, Radiology.

[14]  K. Kihara,et al.  Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. , 2010, Urology.

[15]  R. Montironi,et al.  Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder , 2006, Journal of Clinical Pathology.

[16]  M. Babjuk,et al.  [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update]. , 2012, Actas urologicas espanolas.

[17]  Kei Yamada,et al.  Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. , 2008, Radiology.

[18]  L. Neckers,et al.  ErbB2 and NFκB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder Cancer , 2011, PloS one.

[19]  Katsuyoshi Ito,et al.  Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.

[20]  Masahiko Watanabe,et al.  Diffusion-Weighted Imaging of Malignant Breast Tumors: The Usefulness of Apparent Diffusion Coefficient (ADC) Value and ADC Map for the Detection of Malignant Breast Tumors and Evaluation of Cancer Extension , 2005, Journal of computer assisted tomography.

[21]  S. Groshen,et al.  Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. , 1998, Journal of the National Cancer Institute.

[22]  James M Provenzale,et al.  Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.

[23]  A. Rosenkrantz,et al.  High‐grade bladder cancer: Association of the apparent diffusion coefficient with metastatic disease: Preliminary results , 2012, Journal of magnetic resonance imaging : JMRI.

[24]  J. Montie,et al.  Bladder Cancer in 2010: How Far have We Come? , 2010, Ca.

[25]  K. Kihara,et al.  Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. , 2011, AJR. American journal of roentgenology.

[26]  Adilson Prando,et al.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade , 2009 .

[27]  H J Kim,et al.  Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. , 2012, The British journal of radiology.

[28]  L. Sobin,et al.  Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.

[29]  MULTI-INSTITUTIONAL VALIDATION OF THE PREDICTIVE VALUE OF KI-67 LABELING INDEX IN PATIENTS WITH URINARY BLADDER CANCER , 2009 .

[30]  Kazutaka Saito,et al.  Clinical Investigation : Genitourinary Cancer Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer , 2012 .

[31]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. , 2011, European urology.

[32]  Kazutaka Saito,et al.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness , 2011, European Radiology.

[33]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[34]  S. Shariat,et al.  p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[36]  H. Akaike.  A new look at the statistical model identification , 1974 .